Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epinephrine Causing Adverse Effects in Therapeutic Use”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableStudy completedNCT05253937
What this trial is testing

Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest .

Who this might be right for
Cardiopulmonary ArrestEpinephrine Causing Adverse Effects in Therapeutic Use
Lithuanian University of Health Sciences 160
Not applicableUnknownNCT04428827
What this trial is testing

Outcome of Patients With Primary Aldosteronism

Who this might be right for
Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing AdenomaPrimary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)+6 more
Changi General Hospital 600
Large-scale testing (Phase 3)Study completedNCT04688346
What this trial is testing

Cardiovascular Effects of Racemic Epinephrine Pellets

Who this might be right for
Epinephrine Causing Adverse Effects in Therapeutic Use
University of Washington 13
Post-approval studies (Phase 4)Study completedNCT05667727
What this trial is testing

The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome

Who this might be right for
Shortness of BreathAsthma in ChildrenEpinephrine Causing Adverse Effects in Therapeutic Use+1 more
Oman Medical Speciality Board 30